Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome

S Storti; L Pagano; R Marra; A Grilli; G Falappa; A M De Gaetano; A M Ferrante; B Bizzi

Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome

Blood Coagul Fibrinolysis. 1990 Dec;1(6):743-5.

Authors

S Storti¹, L Pagano, R Marra, A Grilli, G Falappa, A M De Gaetano, A M Ferrante, B Bizzi

Affiliation

¹ Università Cattolica del Sacro Cuore, Rome, Italy.

PMID: 2133253

Abstract

A patient with an inferior vena cava thrombosis in nephrotic syndrome was treated with heparin, AT-III concentrates and urokinase. After a few days on treatment he showed a complete resolution of the thrombosis. We suggest that this therapeutic combination may be a good approach to the treatment of thrombosis in nephrotic syndrome.

Publication types

Case Reports

MeSH terms

Acute Kidney Injury / complications
Adult
Antithrombin III / therapeutic use*
Humans
Male
Nephrotic Syndrome / complications*
Pulmonary Embolism / chemically induced
Thrombolytic Therapy* / adverse effects
Thrombosis / drug therapy*
Thrombosis / etiology
Urokinase-Type Plasminogen Activator / adverse effects
Urokinase-Type Plasminogen Activator / therapeutic use*
Vena Cava, Inferior*

Substances

Antithrombin III
Urokinase-Type Plasminogen Activator